Search

Your search keyword '"Javad Javidnia"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Javad Javidnia" Remove constraint Author: "Javad Javidnia"
58 results on '"Javad Javidnia"'

Search Results

1. Trichophyton indotineae: An Emerging Fungal Pathogen with High Terbinafine Resistance

2. Polymerase Chain Reaction-Restriction Fragment Length Polymorphism, A Rapid and Simple Method for Identification of Pathogenic Fungi

3. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I

4. Candida glabrata oropharyngeal infection in a patient with oral squamous cell carcinoma after COVID-19 infection

5. Predominance of Trichophyton tonsurans causing tinea capitis: A 12-year retrospective study in the north of Iran

6. Investigating intestinal parasitic infections with emphasis on molecular identification of Strongyloides stercoralis and Trichostrongylus colubriformis in north of Iran

7. A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles

8. First report of tinea corporis caused by Trichophyton quinckeanum in Iran and its antifungal susceptibility profile

9. Genetic characterization of Toxoplasma gondii in meat-producing animals in Iran

10. Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazolesusceptible and -resistant Candida albicans

11. Evaluation of Dihydrofolate Reductase (Dhfr) Gene, Related to Plasmodium Falciparum Pyrimethamine Resistance in Imported Malaria Cases in Iran

12. Antifungal Properties of on species: A Systematic Review

13. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae

14. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis

15. Analysis of Criminal Content Censorship (Filtering) from a Jurisprudential Framework

16. Global mortality associated with 33 bacterial pathogens in 2019

17. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates

19. Antifungal Resistance of Clinical Candida albicans Isolates in Iran: A Systematic Review and Meta-Analysis

21. Antifungal Properties of

22. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasizing on the potent inhibitory effect of efinaconazole compared to other drugs

23. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis

24. P055 Antifungal resistance of clinical Candida albicans isolates in Iran: asystematic review and meta-analysis

25. Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans

26. Identification and multilocus genotyping of Toxoplasma gondii isolates from congenital infection in north of Iran

27. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐centre experience in Iran

28. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling

29. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis

30. Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran

32. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice

33. Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects

34. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019

35. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis

36. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study

37. In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis

38. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles

39. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

40. Antifungal Properties of Zataria multiflora on Candida species: A Systematic Review

41. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice

42. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers

43. Cover Image

44. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates

45. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017

46. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?

47. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism

48. Cryptococcus and cryptococcosis in Iran during 1969-2019: A systematic review and meta-analysis

49. A systematic review of Toxoplasma gondii genotypes and feline: Geographical distribution trends

50. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis

Catalog

Books, media, physical & digital resources